AI-based clinical trials solutions market worldwide 2030 forecast
According to some estimates, the global market for artificial intelligence-based solutions in clinical trials will exceed seven billion U.S. dollars by 2030. Compared to around 1.3 billion dollars in 2021, that would be a compound annual growth rate of over 20 percent. The implementation of AI in clinical trials, and before that also in drug discovery, is expected to significantly reduce time and cost in the development phases of new drug candidates.